Kamada (KMDA) Common Equity (2012 - 2026)
Kamada (KMDA) recorded Common Equity of $269.56 million in the quarter ended Jun 30, 2026, up 3.7% from $259.95 million a year earlier and up 3.9% from the prior quarter.
Powered by 
Analysis
Kamada (KMDA) Common Equity (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Kamada reported Common Equity of $269.07 million, up 3.7% from the prior year.
- Annual Common Equity has increased for three straight years, with a five-year compound annual growth rate of 8.5% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Common Equity came in at $259.46 million in the year ended Dec 31, 2024 (+6.3%), $244.02 million in the year ended Dec 31, 2023 (+38.6%), $176.02 million in the year ended Dec 31, 2022 (-0.5%) and $176.82 million in the year ended Dec 31, 2021 (-1.0%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Common Equity in data going back to the quarter ended Jun 30, 2012.
- On a year-over-year basis, Common Equity has increased for 12 consecutive quarters, with growth averaging 3.9% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 43.7% in the quarter ended Mar 31, 2024, against a decline of 99.9% in the quarter ended Jun 30, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $259.39 million (quarter ended Mar 31, 2026), $269.07 million (quarter ended Dec 31, 2025) and $265.23 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Kamada | 497.25 Mn | 206.31 Mn | 22.47 Mn | 269.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 269.56 Mn |
| Mar 31, 2026 | 259.39 Mn |
| Dec 31, 2025 | 269.07 Mn |
| Sep 30, 2025 | 265.23 Mn |
| Jun 30, 2025 | 259.95 Mn |
| Mar 31, 2025 | 251.96 Mn |
| Dec 31, 2024 | 259.46 Mn |
| Sep 30, 2024 | 255.27 Mn |
| Jun 30, 2024 | 251.15 Mn |
| Mar 31, 2024 | 251.15 Mn |
| Dec 31, 2023 | 244.02 Mn |
| Sep 30, 2023 | 238.39 Mn |
| Jun 30, 2023 | 176.75 Mn |
| Mar 31, 2023 | 174.81 Mn |
| Dec 31, 2022 | 176.02 Mn |
| Sep 30, 2022 | 172.55 Mn |
| Jun 30, 2022 | 171,574.00 |
| Mar 31, 2022 | 175.15 Mn |
| Dec 31, 2021 | 176.82 Mn |
| Sep 30, 2021 | 181.61 Mn |
API Access
Kamada Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();